Melatonin protects the esophageal epithelial barrier by suppressing the transcription, expression and activity of myosin light chain kinase through ERK1/2 signal transduction

Cell Physiol Biochem. 2014;34(6):2117-27. doi: 10.1159/000369656. Epub 2014 Nov 28.

Abstract

Background/aims: Dilated intercellular space (DIS) contributes to the pathophysiology of gastroesophageal reflux disease (GERD). Melatonin protects the esophageal mucosa; however, the mechanisms underlying that protection remain unclear.

Methods: Transmission electron microscopy (TEM) was used to evaluate the intercellular spaces in the esophageal epithelium of GERD patients. The Het-1A monolayer barrier function was investigated by measuring transepithelial resistance (TER) and FITC-dextran paracellular permeation. The activity of MLCK was represented by MLC phosphorylation. The expression and phosphorylation of MLCK, MLC and ERK were examined by western blot analysis.

Results: The expression and activity of MLCK and ERK phosphorylation were increased in the esophageal epithelium. The increased expression and activity of MLCK was correlated with dilated intercellular spaces. Upon acid treatment, the Het-1A monolayer permeability was increased. When the Het-1A monolayer was pretreated with melatonin and PD98059 before the acid incubation, the permeability and the expression and phosphorylation of MLCK and ERK decreased.

Conclusion: Melatonin protects the esophageal epithelial barrier by suppressing the transcription, translation and activity of MLCK through ERK1/2 signal transduction. These findings provide a better understanding of the potential clinical application of melatonin in GERD treatment.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Epithelial Cells / drug effects
  • Female
  • Gastroesophageal Reflux / drug therapy*
  • Gastroesophageal Reflux / genetics
  • Gastroesophageal Reflux / pathology
  • Gene Expression Regulation / drug effects
  • Humans
  • Intestinal Mucosa / drug effects
  • MAP Kinase Signaling System / drug effects
  • Male
  • Melatonin / administration & dosage*
  • Middle Aged
  • Myosin-Light-Chain Kinase / biosynthesis
  • Myosin-Light-Chain Kinase / genetics*
  • Tight Junctions / drug effects
  • Tight Junctions / genetics
  • Transcription, Genetic / drug effects*

Substances

  • Myosin-Light-Chain Kinase
  • Melatonin